Enzyme replacement therapy for infantile-onset Pompe disease-Reference-Cited by-同舟云学术

Enzyme replacement therapy for infantile-onset Pompe disease

Published:2017-11-20 Issue:12 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Chen Min¹²³⁴,Zhang Lingli¹²³⁴,Quan Shuyan¹²³⁴

Affiliation:

1. West China Second University Hospital, Sichuan University; Department of Pharmacy; No. 20, Section 4, Renmin South Road Chengdu China 610041

2. Sichuan University, Ministry of Education; Key Laboratory of Birth Defects and Related Diseases of Women and Children; Chengdu China

3. West China Second University Hospital, Sichuan University; Evidence-Based Pharmacy Center; Chengdu China

4. Sichuan University; Department of Obstetrics and Gynecology, West China Second University Hospital; Chengdu China

Publisher

Wiley

Subject

Pharmacology (medical)

Reference45 articles.

1. Enzyme replacement therapy (ERT) with recombinant human acid alpha glucosidase (rhGAA) in infantile onset Pompe disease (IOPD);Kishnani;Journal of Inherited Metabolic Disease,2005

2. Enzyme replacement therapy with recombinant human acid alpha glucosidase (rhGAA) in infantile onset Pompe disease (IOPD);Kishnani;Neuromuscular Disorders : NMD,2005

3. Kishnani PS Corzo D Leslie ND Gruskin D Van der Ploeg A Clancy JP Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease Pediatric Research 2009 329 35

4. Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease;Kishnani;Neurology,2007

5. Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease;Case;Neuromuscular Disorders,2015

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation and management of dyspnea as the dominant presenting feature in neuromuscular disorders;Muscle & Nerve;2024-09-12

2. The outcome of genetic and non-genetic pediatric cardiomyopathies;The Egyptian Heart Journal;2024-04-03

3. Efficacy and safety of enzyme replacement therapy with alglucosidase alfa for the treatment of patients with infantile-onset Pompe disease: a systematic review and metanalysis;Frontiers in Pediatrics;2024-02-15

4. Assessment of Parental Needs and Quality of Life in Children with a Rare Neuromuscular Disease (Pompe Disease): A Quantitative–Qualitative Study;Behavioral Sciences;2023-11-21

5. Pharmacovigilance for rare diseases: a bibliometrics and knowledge-map analysis based on web of science;Orphanet Journal of Rare Diseases;2023-09-26